What is Lapovations?
Lapovations specializes in creating advanced technologies for laparoscopic surgery, with a particular emphasis on improving the safety and efficacy of surgical entry points. Their flagship product, AbGrab, is designed to address the inherent risks associated with abdominal wall elevation during laparoscopic procedures. By offering a clinically refined solution, Lapovations aims to elevate patient safety standards and improve surgical outcomes. The company's focus on innovation targets healthcare professionals and surgical teams seeking cutting-edge tools to optimize their laparoscopic surgery practices.
How much funding has Lapovations raised?
Lapovations has raised a total of $1.3M across 2 funding rounds:
Debt
$24K
Series A
$1.3M
Debt (2021): $24K with participation from PPP
Series A (2023): $1.3M, investors not publicly disclosed
What's next for Lapovations?
The recent major strategic investment positions Lapovations for accelerated growth and market penetration. With a focus on enhancing laparoscopic surgical tools, particularly for critical entry procedures, the company is poised to capitalize on the increasing demand for minimally invasive surgical techniques. This capital infusion will likely support further research and development, expansion of manufacturing capabilities, and broader commercialization efforts. Lapovations' commitment to improving patient safety and surgical efficiency through technological advancement suggests a strong future in the healthcare technology landscape.
See full Lapovations company page
